NFSG
XBI icon

Newbridge Financial Services Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Newbridge Financial Services Group’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.39K Hold
15
– – ﹤0.01% 1053
2026
Q1 		$1.93K Hold
15
– – ﹤0.01% 1024
2025
Q4 		$1.84K Sell
15
-5,548
-100% -$636K ﹤0.01% 1032
2025
Q3 		$557K Sell
5,563
-1,004
-15% -$90.4K 0.08% 174
2025
Q2 		$545K Sell
6,567
-2,379
-27% -$190K 0.09% 173
2025
Q1 		$725K Sell
8,946
-1,639
-15% -$146K 0.18% 99
2024
Q4 		$953K Sell
10,585
-1,419
-12% -$137K 0.24% 76
2024
Q3 		$1.19M Sell
12,004
-596
-5% -$58.6K 0.42% 59
2024
Q2 		$1.17M Buy
12,600
+419
+3% +$37.6K 0.44% 49
2024
Q1 		$1.16M Buy
12,181
+44
+0.4% +$4.08K 0.5% 42
2023
Q4 		$1.08M Buy
12,137
+1,302
+12% +$96.7K 0.53% 33
2023
Q3 		$791K Sell
10,835
-1,229
-10% -$98.2K 0.4% 46
2023
Q2 		$1M Sell
12,064
-143
-1% -$12K 0.49% 31
2023
Q1 		$930K Sell
12,207
-885
-7% -$73.4K 0.49% 34
2022
Q4 		$1.09M Sell
13,092
-528
-4% -$42.7K 0.63% 24
2022
Q3 		$1.08M Buy
13,620
+5,876
+76% +$495K 0.63% 17
2022
Q2 		$575K Buy
7,744
+1,570
+25% +$118K 0.36% 68
2022
Q1 		$555K Buy
6,174
+3,174
+106% +$293K 0.27% 72
2021
Q4 		$336K Sell
3,000
-1,314
-30% -$158K 0.16% 135
2021
Q3 		$542K Buy
4,314
+319
+8% +$41.1K 0.34% 64
2021
Q2 		$541K Buy
3,995
+599
+18% +$78.8K 0.33% 65
2021
Q1 		$461K Sell
3,396
-15
-0.4% -$2.25K 0.34% 64
2020
Q4 		$480K Sell
3,411
-621
-15% -$79.5K 0.4% 54
2020
Q3 		$449K Buy
+4,032
New +$452K 0.44% 50

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Newbridge Financial Services Group's XBI Position: Q2 2026 in Review

Newbridge Financial Services Group held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 15 shares worth $2.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1053.

Newbridge Financial Services Group first reported a position in XBI in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.19M in Q3 2024. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Newbridge Financial Services Group held 15 shares of State Street SPDR S&P Biotech ETF worth $2.39K as of Q2 2026.
  • Newbridge Financial Services Group left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #1053 holding.
  • Newbridge Financial Services Group first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 24 quarters since.
  • Newbridge Financial Services Group's State Street SPDR S&P Biotech ETF position peaked at $1.19M in Q3 2024.
  • 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.